Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moller, D.
Right arrow Articles by Bernstein, I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Moller, D.
Right arrow Articles by Bernstein, I.

Chest, Vol 90, 494-499, Copyright © 1986 by American College of Chest Physicians

ARTICLES

Chronic asthma due to toluene diisocyanate

DR Moller, SM Brooks, RT McKay, K Cassedy, S Kopp and IL Bernstein

Twelve subjects were studied with inhalation challenge testing to toluene diisocyanate (TDI) because of suspected TDI asthma based on a consistent clinical and occupational history. In seven cases, TDI asthma was documented by a positive inhalation challenge to low levels of TDI. Six of the seven TDI reactors had persistent respiratory symptoms and required daily treatment even though they had been removed from isocyanate exposure for intervals as long as 12 years (mean 4.5 years). These six TDI reactors had either dual (four cases) or late bronchospasm (two cases) to less than 20 ppb TDI, and all had a positive methacholine or cold air challenge prior to study. The one TDI reactor with a negative methacholine challenge had a positive (immediate) bronchospastic response to a TDI challenge performed one week after removal from isocyanate exposure. Five workers had a negative TDI challenge, two of whom had persistent respiratory symptoms and positive methacholine challenges at the time of TDI inhalation testing. We conclude that respiratory symptoms may persist following long-term removal from occupational exposure to TDI and are associated with nonspecific bronchial hyperreactivity. The TDI sensitivity may also persist for a long time even in the absence of any additional occupational exposure. Long-term prospective studies of symptomatic isocyanate workers are needed to fully define the extent of this problem.


This article has been cited by other articles:


Home page
 Occup. Environ. Med.Home page
P J Nicholson, P Cullinan, A J Newman Taylor, P S Burge, and C Boyle
Evidence based guidelines for the prevention, identification, and management of occupational asthma
Occup. Environ. Med., May 1, 2005; 62(5): 290 - 299.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. G. Ortega, D. N. Weissman, D. L. Carter, and D. Banks
Use of Specific Inhalation Challenge in the Evaluation of Workers at Risk for Occupational Asthma* : A Survey of Pulmonary, Allergy, and Occupational Medicine Residency Training Programs in the United States and Canada
Chest, April 1, 2002; 121(4): 1323 - 1328.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American College of Chest Physicians.